These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 48896)

  • 1. Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus.
    Doar JW; Wilde CE; Thompson ME; Sewell PF
    Lancet; 1975 Jun; 1(7919):1263-6. PubMed ID: 48896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturity onset diabetes mellitus: response to intensive dietary management.
    Hadden DR; Montgomery DA; Skelly RJ; Trimble ER; Weaver JA; Wilson EA; Buchanan KD
    Br Med J; 1975 Aug; 3(5978):276-8. PubMed ID: 1148773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of type 2 (non-insulin-dependent) diabetic patients with diet alone.
    Wales JK
    Diabetologia; 1982 Sep; 23(3):240-5. PubMed ID: 6751904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet and oral antidiabetic drugs and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus.
    Doar JW; Thompson ME; Wilde CE; Sewell PF
    Br Med J; 1976 Feb; 1(6008):498-500. PubMed ID: 814956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diurnal variation in oral glucose tolerance: blood sugar and plasma insulin levels morning, afternoon, and evening.
    Jarrett RJ; Baker IA; Keen H; Oakley NW
    Br Med J; 1972 Jan; 1(5794):199-201. PubMed ID: 5058728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment.
    Kosaka K; Kuzuya T; Akanuma Y; Hagura R
    Diabetologia; 1980 Jan; 18(1):23-8. PubMed ID: 6988263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta cell dysfunction in maturity-onset diabetes: reversible loss of glucose-induced insulin secretion with retention of response to arginine.
    Savage PJ; Bennion LJ; Flock EV; Bennett PH
    Adv Exp Med Biol; 1979; 119():219-25. PubMed ID: 386726
    [No Abstract]   [Full Text] [Related]  

  • 8. Endogenous insulin secretion measured by C-peptide in maturity-onset diabetes controllable by diet alone.
    Rendell M; Ross DA; Drew HM; Zarriello J
    Arch Intern Med; 1981 Nov; 141(12):1617-22. PubMed ID: 7030247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of energy and carbohydrate restriction in patients with chronic diabetes mellitus.
    Perkins JR; West TE; Sönksen PH; Lowy C; Iles C
    Diabetologia; 1977 Dec; 13(6):607-14. PubMed ID: 590652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of bran on glucose kinetics and plasma insulin in non-insulin-dependent diabetes mellitus.
    Hall SE; Bolton TM; Hetenyi G
    Diabetes Care; 1980; 3(4):520-5. PubMed ID: 6257458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose.
    Wolever TM; Chiasson JL; Csima A; Hunt JA; Palmason C; Ross SA; Ryan EA
    Diabetes Care; 1998 Mar; 21(3):336-40. PubMed ID: 9540012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of indigestible dextrin on sugar tolerance: III. Improvement in sugar tolerance by indigestible dextrin on the impaired glucose tolerance model].
    Wakabayashi S
    Nihon Naibunpi Gakkai Zasshi; 1993 Jun; 69(6):594-608. PubMed ID: 8396049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus.
    Savage PJ; Bennion LJ; Flock EV; Nagulesparan M; Mott D; Roth J; Unger RH; Bennett PH
    J Clin Endocrinol Metab; 1979 Jun; 48(6):999-1007. PubMed ID: 447806
    [No Abstract]   [Full Text] [Related]  

  • 15. Diet and diabetes mellitus.
    Flood TM
    Hosp Pract; 1979 Feb; 14(2):61-9. PubMed ID: 428986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral glucose tolerance and related factors in a normal population sample. I. Blood sugar, plasma insulin, glyceride, and cholesterol measurements and the effects of age and sex.
    Boyns DR; Crossley JN; Abrams ME; Jarrett RJ; Keen H
    Br Med J; 1969 Mar; 1(5644):595-8. PubMed ID: 5766122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of obesity and maturity-onset diabetes on the kinetics of NEFA during oral glucose tolerance tests (OGTT)].
    Pasquali R; Parenti M; Della Rocca E; Rago S; Bianchi V; Gallo C; Calliva R; Melchionda N
    G Clin Med; 1979 Jul; 60(7):549-59. PubMed ID: 398303
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus.
    Watts NB; Spanheimer RG; DiGirolamo M; Gebhart SS; Musey VC; Siddiq YK; Phillips LS
    Arch Intern Med; 1990 Apr; 150(4):803-6. PubMed ID: 2327840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clofibrate on glucose tolerance in maturity onset diabetes.
    Barnett D; Craig JG; Robinson DS; Rogers MP
    Br J Clin Pharmacol; 1977 Aug; 4(4):455-8. PubMed ID: 901737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amiloride on oral glucose loading, serum potassium, renin, and aldosterone in diet-controlled diabetes.
    Lowenthal DT; Gould A; Shirk J; Mazzella J; Affrime MB; Walker F; Onesti G
    Clin Pharmacol Ther; 1980 May; 27(5):671-6. PubMed ID: 6989547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.